PHGDH is Key to a Prognostic Multigene Signature and a Potential Therapeutic Target in Acute Myeloid Leukemia
Journal of Cancer · 2024 · 15 (9) · 2538-2548
DOI: 10.7150/jca.90822 ↗At a glance
Journal article in Journal of Cancer, 2024. Written by Jiagui Zhong and 7 co-authors. Institution: Department of Hematology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China. Cited 7 times so far (Crossref). The full text is freely available in PubMed Central.
Abstract (original language)
Abstract non disponibile.
Subjects
Author keywords
Authors and institutions
- Department of Hematology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China.
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China.
- Department of Hematology, The Affiliated Kashi Hospital, Sun Yat-sen University, Kashi 844099, China.
- Internal Medicine Ward I, JieXi People's Hospital (Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University-JieXi Medical Center), JieYang 515499, China.
Cite
APA
Zhong, J., Huang, K., Xie, S., Tan, A., Peng, J., Nie, D., Ma, L., & Li, Y. (2024). PHGDH is Key to a Prognostic Multigene Signature and a Potential Therapeutic Target in Acute Myeloid Leukemia. Journal of Cancer, 15(9), 2538-2548. https://doi.org/10.7150/jca.90822
Vancouver
Zhong J, Huang K, Xie S, Tan A, Peng J, Nie D, et al. PHGDH is Key to a Prognostic Multigene Signature and a Potential Therapeutic Target in Acute Myeloid Leukemia. Journal of Cancer. 2024;15(9):2538-2548. doi:10.7150/jca.90822
BibTeX
@article{Zhong2024,
author = {Zhong, Jiagui and Huang, Kezhi and Xie, Shaofan and Tan, Ailian and Peng, Jiaqin and Nie, Danian and Ma, Liping and Li, Yiqing},
title = {PHGDH is Key to a Prognostic Multigene Signature and a Potential Therapeutic Target in Acute Myeloid Leukemia},
journal = {Journal of Cancer},
year = {2024},
volume = {15},
number = {9},
pages = {2538--2548},
doi = {10.7150/jca.90822}
}
EUVIMED